Company Filing History:
Years Active: 2025
Title: Innovations by Adrienne Wright in Canine Stem Cell Research
Introduction
Adrienne Wright is a notable inventor based in Manhattan, Kansas, recognized for her contributions to the field of veterinary medicine and stem cell research. She has developed innovative methods for the isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells (UC-MSCs). Her work aims to enhance the viability and handling of these cells, which are crucial for various therapeutic applications.
Latest Patents
Adrienne Wright holds a patent titled "Isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells." This patent includes methods for improved handling of isolated canine UC-MSCs, focusing on their expansion, cryopreservation, and enhanced post-thaw viability using adherent plates. Additionally, it outlines standardized methods and kits for characterizing isolated canine UC-MSCs within a cell population. The patent also discloses methods for improved detachment or dissociation of adherent cells, introducing new dissociation reagents that comprise nattokinase.
Career Highlights
Wright is affiliated with the Kansas State University Research Foundation, where she continues to advance her research in stem cell technology. Her innovative approaches have the potential to significantly impact veterinary medicine and regenerative therapies for dogs.
Collaborations
Adrienne collaborates with Mark L. Weiss, a fellow researcher, to further explore the applications of her patented methods in the field of canine health.
Conclusion
Adrienne Wright's pioneering work in the isolation and expansion of canine umbilical cord mesenchymal stromal cells represents a significant advancement in veterinary medicine. Her contributions are poised to enhance therapeutic options for canine patients, showcasing the importance of innovation in animal health.